Evaluation of the up-to-7 criterion for determining the treatment of hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage B: a single-center retrospective cohort study.

Nong, Xiang; Zhang, Yumei; Xie, Jinlong; Liang, Jingchang; Xie, Aize; Zhang, Zhiming

Nong, Xiang; Zhang, Yumei; Xie, Jinlong; Liang, Jingchang; Xie, Aize; Zhang, Zhiming.

Afiliación

Nong X; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.
Zhang Y; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.
Xie J; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.
Liang J; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.
Xie A; Department of Traditional Chinese Medicine, Guangxi Medical University Cancer Hospital, Nanning, China.
Zhang Z; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.

J Gastrointest Oncol ; 14(2): 768-779, 2023 Apr 29.

Article en En | MEDLINE | ID: mdl-37201043

Palabras clave

Hepatocellular carcinoma (HCC); hepatectomy; transcatheter arterial chemoembolization (TACE); up-to-7 criterion

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Gastrointest Oncol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google